Sonen Capital’s AbbVie ABBV Stock Holding History

Sonen Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$214K	Sell	1,381 -39	-3%	-$5.69K	0.41%	68
2023 Q3	$212K	Buy	+1,420	New	+$208K	0.42%	71
2023 Q2	–	Sell	-1,537	Closed	-$245K	–	83
2023 Q1	$245K	Buy	1,537 +70	+5%	+$10.7K	0.42%	80
2022 Q4	$237K	Buy	+1,467	New	+$225K	0.39%	88
2022 Q3	–	Sell	-1,465	Closed	-$224K	–	99
2022 Q2	$224K	Buy	+1,465	New	+$224K	0.32%	96
2022 Q1	–	Sell	-1,500	Closed	-$203K	–	92
2021 Q4	$203K	Buy	+1,500	New	+$177K	0.2%	104

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sonen Capital's ABBV Position: Q4 2023 in Review

Sonen Capital reduced its AbbVie (ABBV) stake by 2.7% in Q4 2023, selling an estimated $5.69K and leaving 1,381 shares worth $214K. The position accounts for 0.41% of the portfolio, ranked #68.

Sonen Capital first reported a position in ABBV in Q4 2021 and has held it in 6 quarters since. The position peaked at $245K in Q1 2023. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

Sonen Capital held 1,381 shares of AbbVie worth $214K as of Q4 2023.
Sonen Capital sold 39 AbbVie shares in Q4 2023, an estimated $5.69K.
AbbVie made up 0.41% of Sonen Capital's portfolio in Q4 2023, its #68 holding.
Sonen Capital first reported a position in AbbVie in Q4 2021 and has held it in 6 quarters since.
Sonen Capital's AbbVie position peaked at $245K in Q1 2023.
3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Sonen Capital's 13F filing for Q4 2023, filed 2 Feb 2024.